We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$165M
AUM Growth
+$4.34M
Cap. Flow
+$1.88M
Cap. Flow %
1.14%
Top 10 Hldgs %
23.21%
Holding
95
New
1
Increased
36
Reduced
23
Closed

Sector Composition

Rank Sector Weight
1 Industrials 16.35%
2 Technology 12.09%
3 Healthcare 11.32%
4 Financials 10.96%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
51
The Mosaic Company
MOS
$7.09B
$1.41M 0.86%
53,930
+2,295
+4% +$60.9K
JNJ icon
52
Johnson & Johnson
JNJ
$635B
$1.26M 0.76%
10,390
VTI icon
53
Vanguard Total Stock Market ETF
VTI
$654B
$1.25M 0.76%
11,680
HD icon
54
Home Depot
HD
$332B
$1.25M 0.75%
9,755
GOOG icon
55
Alphabet (Google) Class C
GOOG
$3.9T
$1.15M 0.7%
33,300
-100
-0.3% -$3.59K
AMJ
56
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.15M 0.7%
36,190
+1,200
+3% +$35.7K
CVX icon
57
Chevron
CVX
$388B
$1.05M 0.64%
10,062
-50
-0.5% -$5.03K
IAU icon
58
iShares Gold Trust
IAU
$63B
$916K 0.56%
35,915
-125
-0.3% -$3.04K
AOR icon
59
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.63B
$863K 0.52%
21,582
DIS icon
60
Walt Disney
DIS
$165B
$710K 0.43%
7,260
DUK icon
61
Duke Energy
DUK
$102B
$707K 0.43%
8,247
BXP icon
62
Boston Properties
BXP
$11B
$639K 0.39%
4,850
CTAS icon
63
Cintas
CTAS
$82.4B
$621K 0.38%
25,316
PFE icon
64
Pfizer
PFE
$140B
$611K 0.37%
18,310
VEU icon
65
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$594K 0.36%
13,869
-1,690
-11% -$73.2K
SYK icon
66
Stryker
SYK
$127B
$555K 0.34%
4,634
IBM icon
67
IBM
IBM
$202B
$524K 0.32%
3,616
KMB icon
68
Kimberly-Clark
KMB
$36.4B
$508K 0.31%
3,700
AMLP icon
69
Alerian MLP ETF
AMLP
$12.9B
$477K 0.29%
7,511
+266
+4% +$16K
NEE icon
70
NextEra Energy
NEE
$187B
$474K 0.29%
14,560
JPM icon
71
JPMorgan Chase
JPM
$939B
$468K 0.28%
7,536
PAYX icon
72
Paychex
PAYX
$40.4B
$461K 0.28%
7,755
SYY icon
73
Sysco
SYY
$39.7B
$452K 0.27%
8,920
BMY icon
74
Bristol-Myers Squibb
BMY
$127B
$450K 0.27%
6,130
MRK icon
75
Merck
MRK
$324B
$417K 0.25%
7,591

Similar funds

Boston Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Research & Management held 95 positions worth $165M, up 2.7% from $161M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.1%. Boston Research & Management opened 1 new position and made no exits, leaving the 95-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Boston Research & Management's largest Q2 2016 buy was Clorox: 1,530 shares worth $211K.
  • Boston Research & Management added most to iShares Core MSCI Emerging Markets ETF in Q2 2016, an estimated $667K increase.
  • Boston Research & Management's biggest Q2 2016 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $517K.
  • Boston Research & Management's ten largest holdings make up 23% of its $165M portfolio in Q2 2016.
  • Boston Research & Management opened 1 new position and closed 0 in Q2 2016.
  • Boston Research & Management's portfolio value rose 2.7% quarter-over-quarter to $165M.

Based on Boston Research & Management's 13F filing for Q2 2016, filed 10 Aug 2016.